Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc., commonly known as PacBio, is a leading innovator in the medical and precision instruments industry, headquartered in Menlo Park, California, USA. Founded in 2004, the company has made significant strides in genomic sequencing technology, particularly with its unique Single Molecule, Real-Time (SMRT) sequencing platform, which offers unparalleled accuracy and long-read capabilities.
PacBio's core products and services cater to a diverse range of applications, including genomics research, clinical diagnostics, and agricultural biotechnology. The company has established a strong market position, recognised for its contributions to advancing personalised medicine and enhancing our understanding of complex genomes. With a commitment to innovation, PacBio continues to set benchmarks in the field of optical instruments, solidifying its reputation as a key player in the industry.
-12 vs industry average
Pacific Biosciences of California, Inc.’s score of 15 is lower than 26% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Pacific Biosciences of California, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Medical Device Manufacturing has typical carbon intensity
Industry performance
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Reported emissions
No reported emissions data is available for Pacific Biosciences of California, Inc. yet.
Pacific Biosciences of California, Inc.'s reported carbon emissions
Pacific Biosciences of California, Inc. (PacBio), headquartered in the US and operating within the medical, precision and optical instruments industry, has not disclosed specific carbon emissions data in kg CO2e for its operations. Consequently, there are no reported absolute emissions figures or specific reduction targets to report at this time.
As a company in the medical and precision instrument sector, PacBio is part of an industry increasingly focused on environmental stewardship and sustainable practices. While detailed emissions reporting is not yet available, companies in this field are often expected to engage in initiatives aimed at reducing their environmental footprint, which can include energy efficiency measures, responsible waste management, and sustainable sourcing of materials.
PacBio's commitment to climate action, including setting emissions reduction targets, would typically align with broader industry trends and regulatory expectations. Further information on their specific climate commitments would be expected in future disclosures.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Pacific Biosciences of California, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Pacific Biosciences of California, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Pacific Biosciences of California, Inc.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project